Dizziness : Feeling lightheaded can happen, especially when first starting the medication
Stopping can also affect emotional wellbeing
Table 2 Glucose, insulin, C-peptide dynamics, as well as insulin secretion rates and sensitivity after RYGB
It is marketed as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management
Originally, it was developed to treat type 2 diabetes because of its benefits on blood sugar regulation, and has since been licensed for weight loss in obese and overweight people with related health conditions
the enteric-coated MPA formulation has been associated with improved gastrointestinal tolerability, enhanced treatment adherence, and fewer therapy discontinuations in selected transplant recipients